Chapter/Section Purchase

Leave This Empty:

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2024-2030(Status and Outlook)

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Sickle Cell Disease Diagnosis and Treatment
1.2 Key Market Segments
1.2.1 Sickle Cell Disease Diagnosis and Treatment Segment by Type
1.2.2 Sickle Cell Disease Diagnosis and Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Sickle Cell Disease Diagnosis and Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Sickle Cell Disease Diagnosis and Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Sickle Cell Disease Diagnosis and Treatment Market Competitive Landscape
3.1 Global Sickle Cell Disease Diagnosis and Treatment Sales by Manufacturers (2019-2024)
3.2 Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Sickle Cell Disease Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Sickle Cell Disease Diagnosis and Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Sickle Cell Disease Diagnosis and Treatment Sales Sites, Area Served, Product Type
3.6 Sickle Cell Disease Diagnosis and Treatment Market Competitive Situation and Trends
3.6.1 Sickle Cell Disease Diagnosis and Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Sickle Cell Disease Diagnosis and Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Sickle Cell Disease Diagnosis and Treatment Industry Chain Analysis
4.1 Sickle Cell Disease Diagnosis and Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Sickle Cell Disease Diagnosis and Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Sickle Cell Disease Diagnosis and Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Sickle Cell Disease Diagnosis and Treatment Sales Market Share by Type (2019-2024)
6.3 Global Sickle Cell Disease Diagnosis and Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Sickle Cell Disease Diagnosis and Treatment Price by Type (2019-2024)
7 Sickle Cell Disease Diagnosis and Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Sickle Cell Disease Diagnosis and Treatment Market Sales by Application (2019-2024)
7.3 Global Sickle Cell Disease Diagnosis and Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Sickle Cell Disease Diagnosis and Treatment Sales Growth Rate by Application (2019-2024)
8 Sickle Cell Disease Diagnosis and Treatment Market Segmentation by Region
8.1 Global Sickle Cell Disease Diagnosis and Treatment Sales by Region
8.1.1 Global Sickle Cell Disease Diagnosis and Treatment Sales by Region
8.1.2 Global Sickle Cell Disease Diagnosis and Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Sickle Cell Disease Diagnosis and Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Sickle Cell Disease Diagnosis and Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Sickle Cell Disease Diagnosis and Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Sickle Cell Disease Diagnosis and Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Sickle Cell Disease Diagnosis and Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Emmaus Medical
9.1.1 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Basic Information
9.1.2 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Product Overview
9.1.3 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.1.4 Emmaus Medical Business Overview
9.1.5 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment SWOT Analysis
9.1.6 Emmaus Medical Recent Developments
9.2 Addmedica
9.2.1 Addmedica Sickle Cell Disease Diagnosis and Treatment Basic Information
9.2.2 Addmedica Sickle Cell Disease Diagnosis and Treatment Product Overview
9.2.3 Addmedica Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.2.4 Addmedica Business Overview
9.2.5 Addmedica Sickle Cell Disease Diagnosis and Treatment SWOT Analysis
9.2.6 Addmedica Recent Developments
9.3 Gamida Cell
9.3.1 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Basic Information
9.3.2 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Product Overview
9.3.3 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.3.4 Gamida Cell Sickle Cell Disease Diagnosis and Treatment SWOT Analysis
9.3.5 Gamida Cell Business Overview
9.3.6 Gamida Cell Recent Developments
9.4 GlycoMimetics
9.4.1 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Basic Information
9.4.2 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Product Overview
9.4.3 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.4.4 GlycoMimetics Business Overview
9.4.5 GlycoMimetics Recent Developments
9.5 Pfizer
9.5.1 Pfizer Sickle Cell Disease Diagnosis and Treatment Basic Information
9.5.2 Pfizer Sickle Cell Disease Diagnosis and Treatment Product Overview
9.5.3 Pfizer Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Novartis
9.6.1 Novartis Sickle Cell Disease Diagnosis and Treatment Basic Information
9.6.2 Novartis Sickle Cell Disease Diagnosis and Treatment Product Overview
9.6.3 Novartis Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Global Blood Therapeutics
9.7.1 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Basic Information
9.7.2 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Product Overview
9.7.3 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.7.4 Global Blood Therapeutics Business Overview
9.7.5 Global Blood Therapeutics Recent Developments
9.8 Micelle BioPharma
9.8.1 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Basic Information
9.8.2 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Product Overview
9.8.3 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.8.4 Micelle BioPharma Business Overview
9.8.5 Micelle BioPharma Recent Developments
9.9 Bluebird Bio
9.9.1 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Basic Information
9.9.2 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Product Overview
9.9.3 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.9.4 Bluebird Bio Business Overview
9.9.5 Bluebird Bio Recent Developments
9.10 Prolong Pharmaceuticals
9.10.1 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Basic Information
9.10.2 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product Overview
9.10.3 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.10.4 Prolong Pharmaceuticals Business Overview
9.10.5 Prolong Pharmaceuticals Recent Developments
9.11 Modus Therapeutics
9.11.1 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Basic Information
9.11.2 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Product Overview
9.11.3 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.11.4 Modus Therapeutics Business Overview
9.11.5 Modus Therapeutics Recent Developments
9.12 Sangamo Biosciences
9.12.1 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Basic Information
9.12.2 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Product Overview
9.12.3 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.12.4 Sangamo Biosciences Business Overview
9.12.5 Sangamo Biosciences Recent Developments
9.13 Bioverativ
9.13.1 Bioverativ Sickle Cell Disease Diagnosis and Treatment Basic Information
9.13.2 Bioverativ Sickle Cell Disease Diagnosis and Treatment Product Overview
9.13.3 Bioverativ Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.13.4 Bioverativ Business Overview
9.13.5 Bioverativ Recent Developments
9.14 Imara
9.14.1 Imara Sickle Cell Disease Diagnosis and Treatment Basic Information
9.14.2 Imara Sickle Cell Disease Diagnosis and Treatment Product Overview
9.14.3 Imara Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.14.4 Imara Business Overview
9.14.5 Imara Recent Developments
9.15 Ironwood Pharmaceuticals
9.15.1 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Basic Information
9.15.2 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product Overview
9.15.3 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product Market Performance
9.15.4 Ironwood Pharmaceuticals Business Overview
9.15.5 Ironwood Pharmaceuticals Recent Developments
10 Sickle Cell Disease Diagnosis and Treatment Market Forecast by Region
10.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size Forecast
10.2 Global Sickle Cell Disease Diagnosis and Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Sickle Cell Disease Diagnosis and Treatment Market Size Forecast by Region
10.2.4 South America Sickle Cell Disease Diagnosis and Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Sickle Cell Disease Diagnosis and Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Sickle Cell Disease Diagnosis and Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Sickle Cell Disease Diagnosis and Treatment by Type (2025-2030)
11.1.2 Global Sickle Cell Disease Diagnosis and Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Sickle Cell Disease Diagnosis and Treatment by Type (2025-2030)
11.2 Global Sickle Cell Disease Diagnosis and Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Sickle Cell Disease Diagnosis and Treatment Sales (K Units) Forecast by Application
11.2.2 Global Sickle Cell Disease Diagnosis and Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings